Tag: Telehealth

FDA Crackdown Ends the Shortage Loophole: What the New GLP-1 Compounding Rules Mean for Pharmacies

Compounding Pharmacy Josh -
The FDA has closed the shortage loophole that fueled the compounded GLP-1 boom. With semaglutide and tirzepatide off the shortage list, compounding pharmacies and telehealth platforms face a new era of enforcement, audits, and market consolidation.